# FDA Inspection 869813 - The University of Texas Medical Branch at Galveston - March 13, 2014

Source: https://www.keypedia.com/records/fda_inspections/the-university-of-texas-medical-branch-at-galveston/cab91807-2c8d-415f-858f-731130d2a38f
Source feed: FDA_Inspections

> FDA Inspection 869813 for The University of Texas Medical Branch at Galveston on March 13, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 869813
- Company Name: The University of Texas Medical Branch at Galveston
- Inspection Date: 2014-03-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 773236 - 2012-03-21](https://www.keypedia.com/records/fda_inspections/the-university-of-texas-medical-branch-at-galveston/6a1a0d12-b422-4285-8566-da683c058e74)
- [FDA Inspection 649025 - 2010-02-25](https://www.keypedia.com/records/fda_inspections/the-university-of-texas-medical-branch-at-galveston/42bc6fd5-7e93-4d03-8400-7144e2ddbdb5)

Company: https://www.keypedia.com/companies/the-university-of-texas-medical-branch-at-galveston/b36ae08b-9d53-4bf7-9f0c-cec240b305f4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d